How AI is helping solve the labor issue in treating rare diseases Modern biotech has the tools to edit genes and design drugs, yet thousands of rare diseases remain untreated. According to executives from Insilico Medicine and GenEditBio, the missing ingredient for years has been finding enough smart people to continue the work. AI, they say, is becoming the force multiplier that lets...

The backlash over OpenAI’s decision to retire GPT-4o shows how dangerous AI companions can be OpenAI announced last week that it will retire some older ChatGPT models by February 13. That includes GPT-4o, the model infamous for excessively flattering and affirming users. For thousands of users protesting the decision online, the retirement of 4o feels akin to losing a friend, romantic partner,...

Apple's iPhone 17E Is Near and It Needs More Than MagSafeNot all iPhones are released in the fall. Apple is rumored to be launching an iPhone 17E soon. It would be an update to what some call the "budget-friendly" model, but it won't feel too budgety, with an expected $600 price tag. Last year's iPhone 16E dropped in mid-February with a simple press release. But it doesn't mean...

Watch: Ukrainian soldier thought to be dead calls his familyThis is the moment Nazar Daletskyi’s family found out that their relative, who was thought to have died fighting as a Ukrainian soldier in the first year of Russia’s full-scale invasion, was in fact alive.They were told he had died in September 2022 and a few months later they received a body that they believed was his and buried him...

A16z VC wants founders to stop stressing over insane ARR numbers  The AI investing boom (or perhaps bubble) is something Silicon Valley has seen many times before: a gold rush of VC money thrown at the Big New Thing. But one aspect of it is completely unique to these times: startups rocketing from $0 to as much as $100 million in annual recurring revenue, sometimes in a matter of...